IRIS
POLLICINO, Teresa
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.240
EU - Europa 6.624
AS - Asia 3.211
SA - Sud America 1.049
Continente sconosciuto - Info sul continente non disponibili 230
AF - Africa 99
OC - Oceania 13
Totale 18.466
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.030
RU - Federazione Russa 3.234
SG - Singapore 1.243
CN - Cina 1.003
BR - Brasile 917
IE - Irlanda 779
SE - Svezia 707
IT - Italia 540
HK - Hong Kong 376
DE - Germania 305
FR - Francia 205
FI - Finlandia 186
PL - Polonia 182
UA - Ucraina 182
VN - Vietnam 170
GB - Regno Unito 131
IN - India 93
CA - Canada 88
BD - Bangladesh 56
MX - Messico 43
TR - Turchia 39
IQ - Iraq 37
AR - Argentina 34
BE - Belgio 33
ZA - Sudafrica 29
ID - Indonesia 28
ES - Italia 26
CO - Colombia 25
NL - Olanda 23
JP - Giappone 22
PK - Pakistan 22
CZ - Repubblica Ceca 21
EC - Ecuador 21
AT - Austria 19
MA - Marocco 19
UZ - Uzbekistan 18
VE - Venezuela 14
AE - Emirati Arabi Uniti 13
HN - Honduras 13
CR - Costa Rica 11
JM - Giamaica 11
KE - Kenya 11
PY - Paraguay 11
LT - Lituania 9
SA - Arabia Saudita 9
SV - El Salvador 9
JO - Giordania 8
NP - Nepal 8
NZ - Nuova Zelanda 8
PE - Perù 8
TN - Tunisia 8
TT - Trinidad e Tobago 8
CL - Cile 7
CW - ???statistics.table.value.countryCode.CW??? 7
GR - Grecia 7
AZ - Azerbaigian 6
BO - Bolivia 6
CI - Costa d'Avorio 6
KG - Kirghizistan 6
LB - Libano 6
MY - Malesia 6
PH - Filippine 6
PR - Porto Rico 6
UY - Uruguay 6
AL - Albania 5
AU - Australia 5
BG - Bulgaria 5
EG - Egitto 5
GT - Guatemala 5
IL - Israele 5
NI - Nicaragua 5
SC - Seychelles 5
CH - Svizzera 4
EE - Estonia 4
IR - Iran 4
KZ - Kazakistan 4
OM - Oman 4
AO - Angola 3
DO - Repubblica Dominicana 3
DZ - Algeria 3
PS - Palestinian Territory 3
SN - Senegal 3
BB - Barbados 2
BY - Bielorussia 2
ET - Etiopia 2
EU - Europa 2
GP - Guadalupe 2
KR - Corea 2
LK - Sri Lanka 2
LV - Lettonia 2
LY - Libia 2
MD - Moldavia 2
MN - Mongolia 2
NO - Norvegia 2
PT - Portogallo 2
QA - Qatar 2
AM - Armenia 1
BN - Brunei Darussalam 1
BS - Bahamas 1
BW - Botswana 1
Totale 18.227
Salva come PNG Salva come JPEG
Città #
Ashburn 1.525
Moscow 975
Dublin 779
Dallas 737
Singapore 722
Chandler 543
San Jose 440
Nyköping 408
Hong Kong 376
Jacksonville 372
Beijing 359
Messina 259
Council Bluffs 246
Warsaw 167
Los Angeles 158
The Dalles 142
Princeton 119
Ann Arbor 117
Munich 106
Lauterbourg 102
Medford 98
Cambridge 90
Des Moines 86
New York 77
São Paulo 77
Ho Chi Minh City 67
Boardman 65
Santa Clara 57
Houston 54
Dearborn 51
Helsinki 47
Phoenix 44
Buffalo 43
Jinan 41
Turku 40
Frankfurt am Main 37
Wilmington 36
Woodbridge 36
Brasília 34
Orem 33
Brussels 32
Tianjin 32
Hanoi 31
North Bergen 31
Belo Horizonte 29
Guangzhou 29
Pune 28
Redondo Beach 27
San Mateo 27
Atlanta 25
Rome 25
Shanghai 23
Chennai 22
Chicago 22
Rio de Janeiro 22
Brooklyn 21
Denver 21
Falls Church 21
Nanjing 21
Tokyo 21
Shenzhen 19
Boston 18
Columbus 18
Stockholm 18
Zhengzhou 18
Jakarta 17
Mexico City 17
Montreal 17
Nuremberg 17
San Francisco 17
Tashkent 17
Dong Ket 16
Johannesburg 16
Milan 16
Shenyang 15
London 14
Porto Alegre 14
Rosolini 14
Walnut 14
Baghdad 13
Brno 13
Hebei 13
Seattle 13
Amsterdam 12
Dhaka 12
Lahore 12
Lappeenranta 12
Manchester 12
Toronto 12
Haiphong 11
Norwalk 11
Salvador 11
Catania 10
Düsseldorf 10
Guarulhos 10
Mumbai 10
Poplar 10
Fortaleza 9
Haikou 9
Hangzhou 9
Totale 10.821
Salva come PNG Salva come JPEG
Nome #
Impact of hepatitis B virus (HBV) preS/S genomic variability on HBV surface antigen and HBV DNA serum levels. 392
Analysis of haemochromatosis gene mutations in a population from the Mediterranean Basin. 344
Hepatitis B virus (HBV) DNA integration in patients with occult HBV infection and hepatocellular carcinoma. 277
PIVKA-II is a useful tool for diagnostic characterization of ultrasound-detected liver nodules in cirrhotic patients 276
Evaluation of CTNNB1 and TP53 variability in patients with hepatocellular carcinoma and occult hepatitis B virus infection 252
Free episomal and integrated HBV DNA In HBsAg-negative patients with intrahepatic cholangiocarcinoma 236
Lack of the NS5B S282T mutation in HCV isolates from liver tissue of naive patients with HCV genotype-1b infection. 235
Risk Factors Associated with NASH in Obese Patients Undergoing Bariatric Surgery NASH and bariatric surgery 226
Frequency of somatic mutations in TERT promoter, TP53 and CTNNB1 genes in patients with hepatocellular carcinoma from Southern Italy 226
A combination of different diagnostic tools allows identification of inactive hepatitis B virus carriers at a single time point evaluation 226
Non-sequencing molecular approaches to identify preS2-defective hepatitis B virus variants proved to be associated with severe liver diseases 219
NS3 Variability in Hepatitis C Virus Genotype 1A Isolates from Liver Tissue and Serum Samples of Treatment-Naïve Patients with Chronic Hepatitis C 216
Control of cccDNA function in hepatitis B virus infection. 209
Occult hepatitis B virus infection predicts non-alcoholic steatohepatitis in severely obese individuals from Italy 208
Analysis of occult hepatitis B virus infection in liver tissue of HIV patients with chronic hepatitis C. 207
Hepatitis B virus maintains its pro-oncogenic properties in the case of occult HBV infection 206
Behaviour of occult HBV infection in HCV-infected patients under treatment with direct-acting antivirals 199
Analysis of HBV integration in mitochondrial DNA of HepAD38 cells by the high-throughput HBV integration sequencing and RNASeq approaches 196
Cirrhosis related to wild-type HBV infection in siblings with A3 - B35 - Cw4 HLA class I phenotype. 190
AISF position paper on liver transplantation and pregnancy: Women in Hepatology Group, Italian Association for the Study of the Liver (AISF) 190
Occult hepatitis B virus infection is associated with the development of hepatocellular carcinoma in chronic hepatitis C patients. 189
Mitochondrial DNA is a target of HBV integration 189
[A glance into the past ... Southern and northern blot: really superseded?] 188
A 2010 update on occult hepatitis B infection. 186
Is there a downgrading in the alert about the hepatitis B virus infection in Italy? 184
Both interferon alpha and lambda can reduce all intrahepatic HDV infection markers in HBV/HDV infected humanized mice 184
Human hepatitis B virus negatively impacts the protective immune cross-talk between natural killer and dendritic cells 182
Hepatitis B Virus Replication Is Regulated by the Acetylation Status of Hepatitis B Virus cccDNA-Bound H3 and H4 Histones 179
Clinical virology of hepatitis B virus infection 178
Prevalence of hepatitis B and C viral infections in hospitalized patients with increased liver enzyme levels and with no known history of hepatic disease 178
Co-circulation of SARS-CoV-2 Alpha and Gamma variants in Italy, February and March 2021 178
Is investigation of hepatitis C virus NS5A gene heterogeneity a tool for predicting long-lasting response to interferon therapy in patients with HCV-1b chronic hepatitis? 177
Hepatitis E virus infection as a cause of acute hepatitis in Southern Italy 176
Conserved transactivating and pro-apoptotic functions of hepadnaviral X protein in ortho- and avihepadnaviruses. 175
Hepatitis B virus (HBV) induces the expression of interleukin-8 that in turn reduces HBV sensitivity to interferon-alpha. 174
Hepatitis B e antigen detection in formalin-fixed liver biopsy specimens. A tool to investigate wild-type and E-minus variant HBV infection. 172
TT virus has a ubiquitous diffusion in human body tissues: analyses of paired serum and tissue samples. 171
Cutting Edge: Hyperinflammatory Monocytes Expressing CD56 Abound in Severe COVID-19 Patients 170
A roadmap for serum biomarkers for hepatitis B virus: current status and future outlook 167
INTRAHEPATIC HDV RNA, HBV DNA, AND HBV RNAS QUANTIFICATIONS REVEAL SUPPRESSION OF HBV PREGENOME RNA PRODUCTION WITH MAINTENANCE OF PRES/S TRNSCRITION IN HDV/HBV CO-INFECTED PATIENTS 166
Flavocoxid exerts a potent antiviral effect against hepatitis B virus. 166
Divergent effects of interleukin-10 on cytokine production by mononuclear phagocytes and endothelial cells. 165
Disease progression and liver cancer in the ferroportin disease. 164
Replicative and transcriptional activities of hepatitis B virus in patients coinfected with hepatitis B and hepatitis delta viruses. 163
Hepatitis B Virus Causes Epigenetic Induction of Interleukin-8Production which in Turn Inhibits Interferon-alfa Antiviral Activity 163
Risk of occult hepatitis B virus infection reactivation in patients with solid tumours undergoing chemotherapy 163
Genomic heterogeneity of hepatitis B virus (HBV) and outcome of perinatal HBV infection. 162
Obesity and liver cancer 162
HEPATITIS B VIRUS INDUCES INTERLEUKIN-8 (IL8) PRODUCTION IN HEPATOCYTES AND IL-8 IN TURN INHIBITS INTERFERON ALFA ANTIVIRAL ACTIVITY 161
High prevalence of non-organ-specific autoantibodies in hepatitis C virus-infected cirrhotic patients from southern Italy. 159
Infection with HBV preS/S Variants is Highly Prevalent and Influences Amount of Circulating HBsAg Independently of Serum HBV DNA Levels and Response to Interferon Therapy in Chronic Hepatitis B 157
The characteristics of the cell-mediated immune response identify different profiles of occult hepatitis B virus infection. 156
Outcome of liver disease and response to interferon treatment are not influenced by hepatitis B virus core gene variability in children with chronic type B hepatitis. 155
Assessing Genomic Mutations in SARS-CoV-2: Potential Resistance to Antiviral Drugs in Viral Populations from Untreated COVID-19 Patients 153
Ficolin-2 Plasma Level Assesses Liver Fibrosis in Non-Alcoholic Fatty Liver Disease 152
NS3 genetic variability in hepatitis C virus genotype-1b isolates from liver specimens and blood samples of treatment naïve patients with chronic hepatitis C 151
Molecular analyses of TT virus in paired and tissue samples from 150 patients with either hepatic or non-hepatic disease 150
Update of the statements on biology and clinical impact of occult hepatitis B virus infection 150
HEPATITIS B VIRUS INDUCES INTERLEUKIN-8 N(IL-8) PRODUCTION IN HEPATOCYTES AND IL-8 IN TURN INHIBITS INERFERON ALFA ANTIVIRAL ACITIVITY 148
Virological profiles in hepatitis B virus inactive carriers: monthly evaluation in 1-year follow-up study 144
HEPATITIS B VIRUS INDUCES INTERLEUKIN-8 PRODUCTION WHICH IN TURN INHIBITS INTERFERON ALFA ANTIVIRAL ACTIVITY IN HEPATOMA CELL LINES 143
Impact of Occult Hepatitis B Virus Infection on the Outcome of Chronic Hepatitis C. 142
Hepatitis B virus PreS/S gene variants: Pathobiology and clinical implications. 142
Assessing immunological and virological responses in the liver: implications for the cure of chronic hepatitis B virus infection 141
Proliferation of primary human hepatocytes and prevention of hepatitis B virus reinfection efficiently deplete nuclear cccDNA in vivo 141
Hepatitis B virus DNA integration in tumour tissue of a non-cirrhotic HFE-haemochromatosis patient with hepatocellular carcinoma. 140
FULMINANT-HEPATITIS ASSOCIATED WITH THE INTRAFAMILIAR SPREAD OF A PRE-S2 DEFECTIVE HBV VARIANT AND THE LATE EMERGENCE OF HBEAG- MINUS VIRAL STRAINS 138
Neoangiogenesis-related genes are hallmarks of fast-growing hepatocellular carcinomas and worst survival. Results from a prospective study 137
Pre-S2 defective hepatitis B virus infection in patients with fulminant hepatitis. 135
Occult hepatitis B virus in liver tissue of individuals without hepatic disease. 134
Targeting Hepatitis B virus infected cells with a T-cell receptor like antibody 133
PRE-S GENETIC VARIANTS ARE HIGHLY PREVALENT AND SIGNIFICANTLY CORRELATE WITH LOWER LEVELS OF HBSAG IN ACTIVE HBV INFECTIONS 130
Occult hepatitis B infection and hepatocellular carcinoma: Epidemiology, virology, hepatocarcinogenesis and clinical significance 129
Severe outcome of hepatitis B virus (HBV) infection and lack of HBV e antigen-defective virus emergence in patients homozygous for HLA class I alleles. 128
Occult HBV infection 128
Long-term virological and clinical evaluation of chronic hepatitis B patients under nucleos(t)ide analogues therapy 126
Quantification of intrahepatic hepatitis B virus (HBV) DNA in patients with chronic HBV infection. 126
Virological profiles in patients with chronic hepatitis C and overt or occult HBV infection. 125
Occult hepatitis B virus infection in hepatitis C virus negative chronic liver diseases 125
Evaluation of hepatitis B and C virus infections in patients with non-Hodgkin's lymphoma and without liver disease 124
Statements from the Taormina expert meeting on occult hepatitis B virus infection. 124
Molecular and functional analysis of occult hepatitis B virus isolates from patients with hepatocellular carcinoma. 122
NS3 Q80K Polymorphism in viral isolates from Liver Tissues and serum samples of naive HCV genotype 1a Patients 121
Role of humoral immunity against hepatitis B virus core antigen in the pathogenesis of acute liver failure 120
Occult hepatitis B virus infection 119
Integration of hepatitis B virus DNA in chronically infected patients assessed by Alu-PCR. 119
Variability of reverse transcriptase and overlapping S gene in hepatitis B virus isolates from untreated and lamivudine-resistant chronic hepatitis B patients. 118
Infection with hepatitis C virus depends on TACSTD2, a regulator of claudin-1 and occludin highly downregulated in hepatocellular carcinoma 118
Resistance analysis and treatment outcomes in hepatitis C virus genotype 3 infected patients within the Italian network VIRONET-C 116
HBV-integration studies in the clinic: Role in the natural history of infection 115
Occult hepatitis B virus infection: an update 114
Trends in chronic hepatitis B virus infection in Italy over a 10-year period: Clues from the nationwide PITER and MASTER cohorts toward elimination 112
Occult hepatitis B virus infection in patients with chronic hepatitis C liver disease 110
Hepatitis Delta Virus and Hepatocellular Carcinoma 108
Pro-apoptotic effect of the hepatitis B virus X gene. 107
The hepatitis B virus X protein abrogates Bcl-2-mediated protection against Fas apoptosis in the liver. 106
p53-independent apoptotic effects of the hepatitis B virus HBx protein in vivo and in vitro. 106
Transcriptional regulation of miR-224 upregulated in human HCCs by NFκB inflammatory pathways. 106
Frequent NS5A and multiclass resistance in almost all HCV genotypes at DAA failures: What are the chances for second-line regimens? 98
Tracking the progressive spread of the SARS-CoV-2 Omicron variant in Italy, December 2021 to January 2022 97
Totale 16.360
Salva come PNG Salva come JPEG
Categoria #
all - tutte 61.294
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 61.294
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022654 0 0 0 30 57 16 63 33 18 99 99 239
2022/20232.196 164 250 104 176 138 224 45 100 906 14 61 14
2023/2024719 50 111 26 61 41 103 2 228 3 23 20 51
2024/20252.658 47 19 80 227 115 121 137 519 554 150 228 461
2025/20268.402 360 649 611 546 700 1.592 1.013 1.020 1.103 399 181 228
2026/20271.550 225 326 418 581 0 0 0 0 0 0 0 0
Totale 18.466